Vaccine advisers to the US Food and Drug Administration decided unanimously Tuesday in favor of expanding the emergency use authorization of Moderna's Covid-19 vaccine to include older children and teens, ages 6 to 17, saying it would offer more benefits than risks.
تقديرا لمجهود صاحب البوست او المشاركه فانه لا يمكن مشاهدة الروابط إلا بعد التعليق على البوست In appreciation of the efforts of the owner of the post or participation, the links cannot be viewed until after responding to the post or participation
تقديرا لمجهود صاحب البوست او المشاركه فانه لا يمكن مشاهدة الروابط إلا بعد التعليق على البوست In appreciation of the efforts of the owner of the post or participation, the links cannot be viewed until after responding to the post or participation
تقديرا لمجهود صاحب البوست او المشاركه فانه لا يمكن مشاهدة الروابط إلا بعد التعليق على البوست In appreciation of the efforts of the owner of the post or participation, the links cannot be viewed until after responding to the post or participation
تقديرا لمجهود صاحب البوست او المشاركه فانه لا يمكن مشاهدة الروابط إلا بعد التعليق على البوست In appreciation of the efforts of the owner of the post or participation, the links cannot be viewed until after responding to the post or participation
تقديرا لمجهود صاحب البوست او المشاركه فانه لا يمكن مشاهدة الروابط إلا بعد التعليق على البوست In appreciation of the efforts of the owner of the post or participation, the links cannot be viewed until after responding to the post or participation
FDA advisers vote in favor of authorizing Moderna Covid-19 vaccine for ages 6-17
العرض العادي
